RhumbLine Advisers’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-221,871
Closed -$1.34M 2958
2019
Q4
$1.34M Buy
221,871
+5,020
+2% +$30.3K ﹤0.01% 1957
2019
Q3
$781K Buy
216,851
+18,435
+9% +$66.4K ﹤0.01% 2153
2019
Q2
$532K Buy
198,416
+2,817
+1% +$7.55K ﹤0.01% 2334
2019
Q1
$579K Sell
195,599
-2,705
-1% -$8.01K ﹤0.01% 2265
2018
Q4
$315K Buy
198,304
+59,114
+42% +$93.9K ﹤0.01% 2521
2018
Q3
$512K Sell
139,190
-2,078
-1% -$7.64K ﹤0.01% 2268
2018
Q2
$400K Buy
141,268
+4,590
+3% +$13K ﹤0.01% 2401
2018
Q1
$507K Buy
136,678
+7,290
+6% +$27K ﹤0.01% 2208
2017
Q4
$373K Sell
129,388
-28,008
-18% -$80.7K ﹤0.01% 2357
2017
Q3
$707K Buy
157,396
+980
+0.6% +$4.4K ﹤0.01% 2151
2017
Q2
$718K Buy
156,416
+14,657
+10% +$67.3K ﹤0.01% 2129
2017
Q1
$597K Buy
141,759
+10,174
+8% +$42.8K ﹤0.01% 2174
2016
Q4
$543K Buy
131,585
+4,964
+4% +$20.5K ﹤0.01% 2183
2016
Q3
$1.03M Buy
126,621
+2,604
+2% +$21.1K ﹤0.01% 1787
2016
Q2
$967K Buy
124,017
+4,158
+3% +$32.4K ﹤0.01% 1805
2016
Q1
$925K Buy
119,859
+2,334
+2% +$18K ﹤0.01% 1847
2015
Q4
$1.27M Buy
117,525
+14,425
+14% +$156K ﹤0.01% 1651
2015
Q3
$712K Buy
103,100
+678
+0.7% +$4.68K ﹤0.01% 1997
2015
Q2
$907K Sell
102,422
-34,930
-25% -$309K ﹤0.01% 1923
2015
Q1
$1.35M Buy
137,352
+19,730
+17% +$194K ﹤0.01% 1668
2014
Q4
$1.44M Buy
117,622
+9,205
+8% +$113K ﹤0.01% 1566
2014
Q3
$1.08M Buy
108,417
+1,680
+2% +$16.8K ﹤0.01% 1709
2014
Q2
$808K Buy
106,737
+27,817
+35% +$211K ﹤0.01% 1972
2014
Q1
$260K Sell
78,920
-4,710
-6% -$15.5K ﹤0.01% 2624
2013
Q4
$278K Sell
83,630
-9,734
-10% -$32.4K ﹤0.01% 2634
2013
Q3
$282K Buy
93,364
+3,845
+4% +$11.6K ﹤0.01% 2576
2013
Q2
$732K Buy
+89,519
New +$732K ﹤0.01% 1973